Trials / Completed
CompletedNCT04227457
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (actual)
- Sponsor
- Latin American Cooperative Oncology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To describe the overall survival of advanced NSCLC in Latin America.
Detailed description
* To describe demographic and socioeconomic characteristics of patients newly diagnosed with advanced NSCLC * To describe diagnostic methods, pathological profile and disease stage at diagnosis of advanced NSCLC * To describe the practice patterns of therapeutic agents for treatment of advanced NSCLC * To describe treatment responses, progression and survival times. * To describe reasons for treatment discontinuation * To identify associations between patient demographics, socioeconomic, pathology, treatment sequences and overall survival; * To define the patient experience of advanced NSCLC and identify unmet needs in their diagnose and treatment.
Conditions
Timeline
- Start date
- 2018-07-25
- Primary completion
- 2021-10-04
- Completion
- 2023-08-04
- First posted
- 2020-01-13
- Last updated
- 2024-02-20
Locations
27 sites across 5 countries: Argentina, Brazil, Chile, Colombia, Mexico
Source: ClinicalTrials.gov record NCT04227457. Inclusion in this directory is not an endorsement.